Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment.
about
RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiationPeriostin modulates myofibroblast differentiation during full-thickness cutaneous wound repairmPGES-1 null mice are resistant to bleomycin-induced skin fibrosis.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosisUnderstanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.The myofibroblast matrix: implications for tissue repair and fibrosis.Cell-type-specific differentiation and molecular profiles in skin transplantation: implication of medical approach for genetic skin diseases.Linking immune responses with fibrosis in allergic eye disease.Pathogenesis of systemic sclerosis-current concept and emerging treatments.Endothelin-1-induced expression of α-smooth muscle actin in human myometrial fibroblasts.SIRT-1 regulates TGF-β-induced dermal fibroblast migration via modulation of Cyr61 expression.Neural differentiation of rat aorta pericyte cells.Transforming growth factor-β signaling in systemic sclerosis.Induction of heart valve lesions by small-molecule ALK5 inhibitors.
P2860
Q34663751-24E55B89-900D-4294-B873-CDD681239972Q34805707-AB3B6AF1-BD90-48C4-9FE9-7A863B705BC2Q35714565-B6C1F37A-19F9-47AD-B7CE-BD5C5CD6FAA2Q36537631-6805A2E7-3950-4F9E-89A9-EE666740B96EQ37224668-33919153-E647-4A0A-A9D0-DAE3CAC2F92CQ37294119-BD8854D9-483B-4918-A767-A5A6F2FEBA83Q37638268-51FA3E69-9D4C-4857-9656-C12CE4B1C00CQ37690287-ECD589B8-99F0-4F60-A363-0DA24D44679AQ37733670-1517CFBC-8738-419B-8756-BA10F9C21095Q37969117-8BBCE2B5-F061-4FCE-8166-8014D03AFB07Q38563744-6E86B0B7-720D-4178-9511-AAF40F32E72BQ39294794-CA64E597-90E1-4611-9EFA-A8B4184DD9EDQ47261704-F5E8735C-596F-499F-BDA0-F031119110C6Q48020793-AA2C38E9-AA7E-400B-9DB0-9F949C29A5FEQ48849427-CEB16AE7-63C5-4146-92A7-7543B7682821Q49895124-65C55123-D52C-4FE2-A36D-A41433B5AEA7Q51423313-D552D275-13B2-4E71-AC94-D22AD1E9BBAB
P2860
Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Towards an anti-fibrotic thera ...... fferentiation and recruitment.
@en
type
label
Towards an anti-fibrotic thera ...... fferentiation and recruitment.
@en
prefLabel
Towards an anti-fibrotic thera ...... fferentiation and recruitment.
@en
P2860
P356
P1476
Towards an anti-fibrotic thera ...... fferentiation and recruitment.
@en
P2093
Andrew Leask
P2860
P2888
P356
10.1186/1755-1536-3-8
P577
2010-05-27T00:00:00Z
P5875
P6179
1016532314